20-845190-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001042353.3(FAM110A):āc.386G>Cā(p.Arg129Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000166 in 1,566,094 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001042353.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FAM110A | NM_001042353.3 | c.386G>C | p.Arg129Pro | missense_variant | 2/2 | ENST00000381941.8 | NP_001035812.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FAM110A | ENST00000381941.8 | c.386G>C | p.Arg129Pro | missense_variant | 2/2 | 1 | NM_001042353.3 | ENSP00000371367 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152034Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000347 AC: 6AN: 172664Hom.: 0 AF XY: 0.0000519 AC XY: 5AN XY: 96322
GnomAD4 exome AF: 0.0000156 AC: 22AN: 1414060Hom.: 0 Cov.: 35 AF XY: 0.0000200 AC XY: 14AN XY: 700810
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152034Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74280
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 21, 2022 | The c.386G>C (p.R129P) alteration is located in exon 2 (coding exon 1) of the FAM110A gene. This alteration results from a G to C substitution at nucleotide position 386, causing the arginine (R) at amino acid position 129 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at